Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia-Reference-Cited by-同舟云学术

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia

Published:2018-09-25 Issue:2 Volume:10 Page:383-391
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Fukuda Masahiro¹^ORCID,Doi Kunihiro²,Sugawara Masahiro³,Mochizuki Koichi⁴

Affiliation:

1. Fukuda Clinic; Osaka Japan

2. Doi Clinic; Kyoto Japan

3. Sugawara Clinic; Tokyo Japan

4. Mochizuki Naika Clinic; Tokyo Japan

Funder

Japan Physicians Association

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12915/fullpdf

Reference16 articles.

1. Ministry of Health, Labour and Welfare of Japan The National Health and Nutrition Survey 2016 http://www.mhlw.go.jp/bunya/kenkou/kenkou_eiyou_chousa.html

2. Hypoglycemia in older people - a less well recognized risk factor for frailty;Abdelhafiz;Aging Dis,2015

3. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus;Whitmer;JAMA,2009

4. Correlates of quality of life in older adults with diabetes: the diabetes & aging study;Laiteerapong;Diabetes Care,2011

5. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study;Bonds;BMJ,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study);Diabetes Therapy;2024-04-24

2. Expert consensus recommendations on the evaluation and management of hypoglycemia in diabetes: DGENius Group Diabetes India;Journal of Diabetology;2024-01

3. Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study);Diabetes Therapy;2023-07-19

4. Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study);Diabetes Therapy;2023-07-06

5. Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study;Scientific Reports;2023-01-04